CR Medicon

A comparative overview of clinical trial regulation between the US and China, the world’s two largest healthcare markets.

http://ow.ly/A0EX50xPmkU

US-China Clinical Trial Regulatory Overview - CR Medicon In this CR Medicon publication, we give a side-by-side comparative overview of clinical trial regulatory commonalities and differences between the US and China. This is a must-read if you plan to enter your pharmaceutical and medical products into the world’s two largest healthcare markets.

Innovative chemical drug development in China on the rise.

Pharmaceutical companies’ investment in innovative chemical drug R&D has continued to increase with a five-year growth rate of nearly four times.

Read more here;
http://ow.ly/1YHA50xPlzX

Innovative Chemical Drug Development in China - CR Medicon R&D in innovative chemical drugs in China has continued to increase, from 4.6 billion yuans in 2013 to 18.4 billion yuans in 2018. Download CR Medicon's report about the latest China's innovative chemical drug development. .

We are hiring for Director of Business Development at CR Medicon locations in Boston MA and the West Coast area. Learn more about this position.


http://ow.ly/GukC50xgwPM